Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1996-1-4
|
pubmed:abstractText |
This study investigated the utility of the Point Subtraction Aggression Paradigm (PSAP), a computerized laboratory analog aggression measure. We measured the effects of methylphenidate (MPH) on aggressive responding in children with a DSM-III-R diagnosis of attention deficit hyperactivity disorder (ADHD), who had high ratings on the Child Behavior Checklist Aggression Factor (CBCL; Achenbach 1991). Results are reported for 6 subjects, ages 8-11 years. All were tested at baseline in an unmedicated condition, and after double-blind administration of placebo, 0.3 mg/kg of MPH, and 0.6 mg/kg of MPH. A main effect of decreased aggressive responding with MPH was found, with a dose-related change by repeated measures ANOVA (F = 6.59, df = 2.10, p = .014). Post-hoc analysis with the Tukey HSD indicated that only the 0.6 mg/kg was significantly (p < .05) different than placebo. Implications for use of the PSAP in future investigations of medications in aggressive children are discussed.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0048-5764
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
31
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
353-6
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:7491391-Aggression,
pubmed-meshheading:7491391-Attention Deficit Disorder with Hyperactivity,
pubmed-meshheading:7491391-Child,
pubmed-meshheading:7491391-Dose-Response Relationship, Drug,
pubmed-meshheading:7491391-Humans,
pubmed-meshheading:7491391-Male,
pubmed-meshheading:7491391-Methylphenidate,
pubmed-meshheading:7491391-Psychiatric Status Rating Scales
|
pubmed:year |
1995
|
pubmed:articleTitle |
Methylphenidate effects on a laboratory aggression measure in children with ADHD.
|
pubmed:affiliation |
Center for Mental Health, Charlotte, NC 28211, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|